Amethyst, the European radiotherapy clinics chain linked to Romania, switches ownership
Amethyst Radiotherapy Clinics: A Massive European Acquisition
Hold onto your seats, folks! The British investment fund Fremman Capital is making headlines with its acquisition of the Amethyst Radiotherapy clinics chain. This European powerhouse, rooted in Romania, has caught the eye of Fremman Capital, as reported by Profit.ro.
Before we dig deeper, let's take a step back and understand Amethyst's humble beginnings. Ludovic Robert, a French investor with a background in Romania's pharmaceutical industry (A&D Pharma), and Avner Goldenberg, an accomplished shareholder of various Romanian companies like dialysis clinics Nefromed, launched Amethyst in 2010.
Setting up shop in Romania, Amethyst expanded its footprint to become one of Europe's largest independent networks of cancer treatment centers. As of current, it operates 19 centers across France, Poland, Romania, the UK, Italy, and Austria, treating over 50,000 patients yearly. To add to this impressive figure, 16 operational clinics in 6 countries (Austria, France, Italy, Poland, Romania, UK) are part of the Amethyst family.
After a short stint with American investment firm The Rohatyn Group (TRG) in 2019, Amethyst received a massive EUR 300 million in funding from Ares Management Corporation to invest in cutting-edge radiotherapy technologies and establish new treatment centers across Europe.
Fast forward to 2022, and Fremman Capital stepped in to acquire the Amethyst Radiotherapy clinics chain from its founding shareholders and TRG. This deal means that TRG is now out of the picture as shareholders in Amethyst, with Fremman Capital taking the reins as the primary shareholder of Amethyst Healthcare Group.
So, there you have it! Keep an eye on this dynamic European healthcare powerhouse as it continues to blaze new trails in radiotherapy treatment.
iulian@our website
(Photo source: the company)
- The acquisition of Amethyst Radiotherapy clinics by Fremman Capital signifies a significant investment in the European health-and-wellness sector, particularly in medical-conditions like cancer treatment.
- Amethyst's origins are traced back to Romania, where French investor Ludovic Robert, with a background in the country's pharmaceutical industry, and Avner Goldenberg, known for his investment in businesses like Romania's dialysis clinics Nefromed, established the company in 2010.
- Amethyst has grown to become one of Europe's largest independent networks of cancer treatment centers, with 19 centers across six countries and treating over 50,000 patients annually.
- In 2019, Amethyst received a substantial EUR 300 million in funding to invest in science and technology, aiming to establish new radiotherapy treatment centers across Europe.
- The recent acquisition by Fremman Capital may lead to further growth and development in the field of finance and business for Amethyst Healthcare Group, as they take control from the founding shareholders and former shareholder, The Rohatyn Group (TRG).
